Fitzgerald Meghan
SEC CIK 1349297 · EDGAR
BoughtSold
Most active insiders at ROIV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MANCHESTER KEITH S | Dir | — | $154.47M |
| 2 | Gold Daniel Allen | Dir | — | $147.38M |
| 3 | QVT Financial LP | Dir by Deputization | — | $147.38M |
| 4 | Sukhatme Mayukh | Pres, CIO, Dir | — | $109.13M |
| 5 | Ramaswamy Vivek | 10% | — | $105.88M |
| 6 | Venker Eric | Pres, Immunovant CEO | — | $89.77M |
| 7 | Torti Frank | Pres, Vant COB | — | $82.04M |
| 8 | Gline Matthew | CEO, Dir | — | $46.17M |
| 9 | Pulik Richard | CFO | — | $9.12M |
| 10 | Fitzgerald Meghan | Dir | — | $3.27M |
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-18 18:57 | 2026-09-16 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | A - Grant | $0.00 | +5,054 | 41.2K | +14% | $0 |
| MT | 2026-09-17 18:42 | 2026-09-15 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | S - Sale | $39.74 | -5,112 | 36.1K | -12% | -$203.2K |
| 2026-09-14 18:29 | 2026-09-10 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | F - Tax | $40.94 | -1,743 | 41.2K | -4% | -$71.4K | |
| DT | 2026-09-10 21:00 | 2026-09-08 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | M - OptEx | $8.80 | +20.0K | 63.0K | +47% | +$176.0K |
| DT | 2026-09-10 21:00 | 2026-09-08 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | S - Sale+OE | $39.90 | -20.0K | 43.0K | -32% | -$798.0K |
| DT | 2026-07-02 19:03 | 2026-06-30 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | M - OptEx | $8.80 | +10.0K | 53.0K | +23% | +$88.0K |
| DT | 2026-07-02 19:03 | 2026-06-30 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | S - Sale+OE | $34.90 | -10.0K | 43.0K | -19% | -$349.0K |
| D | 2026-05-26 20:00 | 2026-05-22 | THC | TENET HEALTHCARE CORP | Fitzgerald Meghan | Dir | M - OptEx | — | +1,333 | 17.6K | +8% | — |
| D | 2026-05-26 20:00 | 2026-05-22 | THC | TENET HEALTHCARE CORP | Fitzgerald Meghan | Dir | D - Sale to Iss | $173.78 | -493 | 17.1K | -3% | -$85.7K |
| D | 2026-03-30 | 2026-03-26 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | M - OptEx | $8.80 | +70.0K | 113.0K | +163% | +$616.0K |
| D | 2026-03-30 | 2026-03-26 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | S - Sale+OE | $27.45 | -70.0K | 43.0K | -62% | -$1.92M |
| D | 2025-09-12 | 2025-09-10 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | A - Grant | $0.00 | +14.5K | 43.9K | +49% | $0 |
| D | 2025-09-12 | 2025-09-10 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | J - Other | $13.77 | -937 | 43.0K | -2% | -$12.9K |
| D | 2025-05-27 | 2025-05-23 | THC | TENET HEALTHCARE CORP | Fitzgerald Meghan | Dir | D - Sale to Iss | $161.33 | -573 | 16.2K | -3% | -$92.4K |
| D | 2025-05-27 | 2025-05-23 | THC | TENET HEALTHCARE CORP | Fitzgerald Meghan | Dir | M - OptEx | — | +1,551 | 16.8K | +10% | — |
| 2024-09-16 | 2024-09-12 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | J - Other | $12.12 | -894 | 29.4K | -3% | -$10.8K | |
| D | 2024-09-12 | 2024-09-10 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | A - Grant | $0.00 | +16.4K | 30.3K | +118% | $0 |
| 2024-08-08 | 2024-08-06 | THC | TENET HEALTHCARE CORP | Fitzgerald Meghan | Dir | S - Sale | $146.34 | -20.0K | 15.3K | -57% | -$2.93M | |
| T | 2024-04-26 | 2024-04-24 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | A - Grant | $0.00 | +1,261 | 13.9K | +10% | $0 |
| T | 2024-04-26 | 2024-04-24 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | F - Tax | $10.90 | -83 | 13.9K | -0.6% | -$904.70 |
| 2024-01-23 | 2024-01-19 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | A - Grant | $0.00 | +1,328 | 12.7K | +12% | $0 | |
| 2023-10-18 | 2023-10-16 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | A - Grant | $0.00 | +1,269 | 11.4K | +13% | $0 | |
| D | 2023-09-14 | 2023-09-12 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | A - Grant | $0.00 | +8,937 | 10.1K | +776% | $0 |
| 2023-07-06 | 2023-07-03 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | A - Grant | $0.00 | +1,152 | 1,152 | New | $0 | |
| A | 2023-06-23 | 2023-05-26 | THC | TENET HEALTHCARE CORP | Fitzgerald Meghan | Dir | A - Grant | $0.00 | +3,682 | 35.3K | +12% | $0 |
| 2023-05-30 | 2023-05-26 | THC | TENET HEALTHCARE CORP | Fitzgerald Meghan | Dir | A - Grant | $0.00 | +2,846 | 34.4K | +9% | $0 | |
| 2022-05-11 | 2022-05-09 | THC | TENET HEALTHCARE CORP | Fitzgerald Meghan | Dir | A - Grant | $0.00 | +3,836 | 31.6K | +14% | $0 | |
| 2021-09-20 | 2021-09-16 | THC | TENET HEALTHCARE CORP | Fitzgerald Meghan | Dir | S - Sale | $72.70 | -6,077 | 27.8K | -18% | -$441.8K |
Purchase Sale Sale after option exercise All abbreviations